Table 5. Multivariate analysis of factors associated with progression free survival in patients receiving SIRT .
| Variable | Overall PFS HR | 95% CI | Overall PFS | Intrahepatic PFS | Distant PFS |
|---|---|---|---|---|---|
| ECOG 0,1 v ≥2 | 0.310 | 0.003-0.276 | 0.0019 | 0.0012 | 0.0012 |
| Pre PLR | 1.002 | 1-1.003 | 0.0319 | – | – |
| ΔPLR | 1.178 | 1.054-1.318 | 0.0040 | 0.0271 | 0.0192 |
| Liver tumor volume | 1.001 | 1-1.002 | 0.0425 | 0.0425 | 0.0196 |
SIRT, selective internal radiation therapy; PFS, progression free survival; HR, hazard ratio; ECOG, Eastern Cooperative Oncology Group; NLR, neutrophil-to-lymphocyte; PLR, platelet-to-lymphocyte ratios.